The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance (Q44802535)

6 December 2017

The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance (English)

1 reference

6 December 2017

Ismael Riquelme

2

0 references

Juan Carlos Roa

object named as

Juan Carlos Roa

11

0 references

author name string

Oscar Tapia

1

1 reference

6 December 2017

Pamela Leal

3

1 reference

6 December 2017

Alejandra Sandoval

4

1 reference

6 December 2017

Susana Aedo

5

1 reference

6 December 2017

Helga Weber

6

1 reference

6 December 2017

Pablo Letelier

7

1 reference

6 December 2017

Enrique Bellolio

8

1 reference

6 December 2017

Miguel Villaseca

9

1 reference

6 December 2017

Patricia Garcia

10

1 reference

6 December 2017

language of work or name

1 reference

21 May 2014

1 reference

6 December 2017

1 reference

6 December 2017

465

1 reference

6 December 2017

1

1 reference

6 December 2017

25-33

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-014-1588-4

6 December 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Incidence and survival of stomach cancer in a high-risk population of Chile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

mTOR as a therapeutic target in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

21 January 2018

mTOR and cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

PI3K/Akt signalling pathway and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Activation of AKT kinases in cancer: implications for therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Risk of colorectal and other gastro-intestinal cancers after exposure to nitrate, nitrite and N-nitroso compounds: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Meta-analysis of the relationship between cagA seropositivity and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

21 January 2018

AKT-ing via microRNA.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

miRBase: integrating microRNA annotation and deep-sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

TOR signaling in growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

A comprehensive map of the mTOR signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

21 January 2018

Expanding mTOR signaling

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Perturbations of the AKT signaling pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Frequent activation of AKT2 kinase in human pancreatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Functional and therapeutic significance of Akt deregulation in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Up-regulation of PIK3CA promotes metastasis in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Activated Akt as an indicator of prognosis in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

PI3K/Akt/mTOR pathway as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Relation between outcomes and localisation of p-mTOR expression in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Signaling pathways in cancer and embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Promoter methylation and silencing of PTEN in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

PI3K and cancer: lessons, challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1588-4

Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis

21 January 2018

1 reference

12 December 2020

Family history and the risk of stomach and colorectal cancer

1 reference

12 December 2020

Red meat, family history, and increased risk of gastric cancer with microsatellite instability.

1 reference

12 December 2020

Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth

1 reference

12 December 2020

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

1 reference

12 December 2020

Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation

1 reference

12 December 2020

Guidelines for the management of oesophageal and gastric cancer

1 reference

12 December 2020

Nutrient intake and risk of subtypes of esophageal and gastric cancer.

1 reference

12 December 2020

[Recommendations for clinical practice: 2004 Standards, Options and Recommendations for management of patients with adenocarcinomas of the stomach (excluding cardial and other histological forms of cancer) Federation nationale des centres de lutte c

1 reference

12 December 2020

Salt intake, cured meat consumption, refrigerator use and stomach cancer incidence: a prospective cohort study (Netherlands)

1 reference

12 December 2020

Gastric cancer treatment guidelines in Japan

1 reference

12 December 2020

Mutation analysis of tumor suppressor gene PTEN in patients with gastric carcinomas and its impact on PI3K/AKT pathway.

1 reference

12 December 2020

AKT and cancer--is it all mTOR?

1 reference

12 December 2020

Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.

1 reference

12 December 2020

10.1007/S00428-014-1588-4

Identifiers

DOI

1 reference

6 December 2017

1 reference